Diagnostic kits for personalized medicine - predicting resistance to chemotherapy treatments

Doctoral student and Kaye Innovation Award winner Ido Sagi at the Hebrew University of Jerusalem (Credit: Hebrew University)

Potential for regenerative medicine and cancer research earns doctoral student Ido Sagi a Kaye Innovation Award

Stem cell research holds huge potential for medicine and human health. In particular, human embryonic stem cells (ESCs), with their ability to turn into any cell in the human body, are essential to the future prevention and treatment of disease.

One set or two? Diploid versus haploid cells

Most of the cells in our body are diploid, which means they carry two sets of chromosomes — one from each parent. Until now, scientists have only succeeded in creating haploid embryonic stem cells — which contain a single set of chromosomes — in non-human mammals such as mice, rats and monkeys. However, scientists have long sought to isolate and replicate these haploid ESCs in humans, which would allow them to work with one set of human chromosomes as opposed to a mixture from both parents.

This milestone was finally reached when Ido Sagi, working as a PhD student at the Hebrew University of Jerusalem’s Azrieli Center for Stem Cells and Genetic Research, led research that yielded the first successful isolation and maintenance of haploid embryonic stem cells in humans. Unlike in mice, these haploid stem cells were able to differentiate into many other cell types, such as brain, heart and pancreas, while retaining a single set of chromosomes.

With Prof. Nissim Benvenisty, Director of the Azrieli Center, Sagi showed that this new human stem cell type will play an important role in human genetic and medical research. It will aid our understanding of human development – for example, why we reproduce sexually instead of from a single parent. It will make genetic screening easier and more precise, by allowing the examination of single sets of chromosomes. And it is already enabling the study of resistance to chemotherapy drugs, with implications for cancer therapy.

Diagnostic kits for personalized medicine

Based on this research, Yissum, the Technology Transfer arm of the Hebrew University, launched the company New Stem, which is developing a diagnostic kit for predicting resistance to chemotherapy treatments. By amassing a broad library of human pluripotent stem cells with different mutations and genetic makeups, NewStem plans to develop diagnostic kits for personalized medication and future therapeutic and reproductive products.

Learn more: First ‘haploid’ human stem cells could change the face of medical research; earn Kaye Innovation Award

The Latest on: Haploid embryonic stem cells

[google_news title=”” keyword=”haploid embryonic stem cells” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]

Stem Cells News
on September 22, 2023 at 5:00 pm
21, 2023 — Despite being an essential developmental process, the understanding of human embryonic genome activation ... Newly Discovered Bone Stem Cell Causes Premature Skull Fusion Sep. 20 ...
Study provides insights into human 8-cell-like cells and early embryonic development
on September 22, 2023 at 2:26 pm
The onset of embryo-specific gene transcription, also known as embryonic genome ... each other and with 8-cell-stage blastomeres. Their findings were made available online on July 20, 2023, and ...
Jerusalem and Toronto scientists reveal different DNA densities in stem cells
on September 20, 2023 at 3:33 am
HP1α bodies can be observed. These bodies exhibit phase separation, forming distinct liquid sub-domains with varying densities, as represented by the light blue and blue regions, respectively...
Embryonic Stem Cells News and Research
on September 17, 2023 at 5:00 pm
Researchers evaluate post-implantation development in humans using embryo-like models based on genetically unmodified human naïve embryonic stem cells. As a human embryo grows, a set of molecules ...
Pluripotent stem cells articles from across Nature Portfolio
on September 13, 2023 at 5:01 pm
Embryonic stem cells and induced pluripotent stem cells are pluripotent stem cells. The role of microglia in amyotrophic lateral sclerosis (ALS) is unclear. Here, the authors show that iPSC ...
Stem Cells in Reproductive Medicine
on August 31, 2023 at 6:59 pm
trophoblasts and endometrium from human embryonic and adult stem cells. Although focussing mainly on the practical elements of the use of stem cells in reproductive medicine, the book also contains a ...
Nuclear Transplantation, Embryonic Stem Cells, and the Potential for Cell Therapy
on July 7, 2023 at 2:15 pm
However, when explanted in culture, this embryo can give rise to embryonic stem cells that have the potential to become any or almost any type of cell present in the adult body. Because embryonic ...
Embryonic stem cells
on October 11, 2022 at 3:49 am
Embryonic stem cells (ESCs or ES cells) are cells from the early embryonic development, from which all cells and organs of an individual descend. Embryonic stem cells are pluripotent, meaning that ...
Oocytes from Stem Cells
on January 12, 2022 at 2:02 pm
1 Starting with mouse embryonic stem cells, these investigators generated ... Meiosis ensures that each female gamete is haploid and thus will complement the equivalent paternal contribution ...
Haploid Human Embryonic Stem Cells (IMAGE)
on September 21, 2021 at 10:54 pm
Shown here are haploid human embryonic stem cells with only one set of chromosomes. Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert!